In the developing retina, a retinoic acid (RA) gradient along the dorso-ventral axis is believed to be a prerequisite for the establishment of dorso-ventral asymmetry. This RA gradient is thought to result from the asymmetrical distribution of RA-generating aldehyde dehydrogenases along the dorso-ventral axis. Here, we identi®ed a novel aldehyde dehydrogenase speci®cally expressed in the chick ventral retina, using restriction landmark cDNA scanning (RLCS). Since this molecule showed enzymatic activity to produce RA from retinaldehyde, we designated it retinaldehyde dehydrogenase 3 (RALDH-3). Structural similarity suggested that RALDH-3 is the orthologue of human aldehyde dehydrogenase 6. We also isolated RALDH-1 which is expressed in the chick dorsal retina and implicated in RA formation. Raldh-3 was preferentially expressed ®rst in the surface ectoderm overlying the ventral portion of the prospective eye region and then in the ventral retina, earlier than Raldh-1 in chick and mouse embryos. High level expression of Raldh-3 was also observed in the nasal region. In addition, we found that Pax6 mutants are devoid of Raldh-3 expression. These results suggested that Raldh-3 is the key enzyme in the formation of an RA gradient along the dorso-ventral axis during the early eye development, and also in the development of the olfactory system. q
Introduction
The development of the eye has been studied using classical embryological methods in the chick and amphibia. These experiments de®ned the interaction between tissues during the formation of eye structures. Development of the eye can be subdivided into three phases. The ®rst phase is the formation of the major structures of the eye by the processes of induction and regional speci®cation. The second is the maturation of these structures to form the functional eye, and the third phase is the formation of neuronal connections between the retina and optic tectum. The ®rst phase in which retinal regional speci®city is established along the naso-temporal (antero-posterior) and dorsoventral axes is closely related to the topographic retinotectal projection in the third phase. We and another group previously found that two winged-helix transcription factors, BF-1 and BF-2, are expressed speci®cally in the nasal and temporal regions of the embryonic retina, respectively (Hatini et al., 1994; Yuasa et al., 1996) . We further showed that misexpression of these factors in the retina lead to misprojection of retinal axons on the tectum along the rostrocaudal axis (Yuasa et al., 1996) . As for the dorsoventral axis, Tbx5 is expressed predominantly in the dorsal retina (Ohuchi et al., 1998) , and cVax (Vax2 in mouse) and Pax2 are expressed in the ventral retina (Schulte et al., 1999) . Misexpression of Tbx5 or cVax in chick retina also caused targeting errors of retinal ganglion cell axons (Schulte et al., 1999; Koshiba-Takeuchi et al., 2000) .
For the region-speci®c expressions, it has been reported that diffusible inducers are involved in the regulation of these transcription factors during early development. FGF-8 is known to be an inducer of BF-1 expression in the developing forebrain and nasal retina, and therefore, implicated in the determination of the naso-temporal axis in the retina (Shimamura and Rubenstein, 1997) . The vitamin A derivative, retinoic acid (RA), gradient is also believed to be a prerequisite for establishment of dorso-ventral asymmetry in the retina. De®ciency of vitamin A in rat embryos results in abnormalities in eye formation: the eyes are small or missing, and mainly a reduction in size of the ventral half is observed (Warkany and Schraffenberger, 1946) . In zebra®sh, perturbation of the RA level in the early embryonic stage leads to a drastic malformation of retina (MarshArmstrong et al., 1994; Hyatt et al., 1996) : the duplication of retina is observed when exogenous RA is applied to embryo (Hyatt et al., 1996) , and the elimination of the ventral half of retina occurs when RA is depleted (MarshArmstrong et al., 1994) . Symptoms similar to vitamin A de®ciency have been observed in double knock-out mice for RA receptors, in which the ventral half of the retina is reduced in size (Kastner et al., 1994; Ghyselinck et al., 1997) . These results indicate that RA functions as a regulator of gene expressions through activation of RA receptors in the retina.
RA is synthesized irreversibly by cytosolic retinaldehyde dehydrogenases, which are members of the aldehyde dehydrogenase (ALDH) family. The earliest RA-generating enzyme expressed in the embryo is retinaldehyde dehydrogenase type 2 (RALDH-2). It was recently reported that Raldh-2-de®cient mice died at midgestation with severe malformation especially in the trunk region (Niederreither et al., 1999) . The null-mutant mice reproduced most of the defects observed in vitamin A-de®cient embryos or knockout mice of RA receptors, which emphasized the importance of RA-generating enzymes in the exertion of RA functions in vivo. However, because some RA was still detectable in the optic vesicles, and no defects in the eye regions were reported in Raldh-2-de®cient mice (Niederreither et al., 1999) , it is evident that other RA-generating enzymes mainly contribute to the development of the eye region. In the retina, two RAgenerating aldehyde dehydrogenases are known to be expressed in an asymmetric manner: one is dorsal-speci®c retinaldehyde dehydrogenase 1 (RALDH-1, equal to mouse AHD2, human ALDH1 and chick ALDH) (Green®eld and Pietruszko, 1977; Lee et al., 1991; Dockham et al., 1992; Godbout, 1992) , and the other is a ventral-speci®c enzyme which has not been cloned. It was suggested from enzyme assays that the ventral-speci®c enzyme has more powerful RA-generating activity than dorsal RALDH-1 (McCaffery et al., 1992) . Thus, it is likely that the ventral-speci®c enzyme mainly contributes to the RA gradient along the dorso-ventral axis.
To understand the molecular mechanism for the establishment of regional speci®city during retinal development, it is important to make up a catalogue of the molecules with asymmetrical expressions in the developing retina. To address this issue, we have performed a large-scale screening using restriction landmark cDNA scanning (RLCS). RLCS is a new cDNA display method, in which many cDNA species derived from respective mRNAs are displayed as two-dimensional spots with signal intensities re¯ecting their expression levels (Suzuki et al., 1996) . Using this method, we successfully identi®ed a number of molecules which showed asymmetrical expression along the antero-posterior or dorso-ventral axis in the developing chick retina. Among them, we identi®ed two aldehyde dehydrogenases: one was a ventral retina-speci®c V/BglII #1 and the other was dorsal retina-speci®c RALDH-1. As V/BglII #1 showed activity to generate RA from retinaldehyde, we designate this novel molecule retinaldehyde dehydrogenase 3 (RALDH-3). We analyzed the expression of these two RALDH during chick and mouse development to elucidate the role of RA in eye formation. Furthermore we found that Raldh-3 expression is absent in Pax6 mutant embryos.
Results
In lower vertebrates including the chick, retinal ganglion cell axons mainly innervate the contralateral tectum according to the spatial order determined by their respective positions in the retina. It is believed that graded distributions of topographic molecules along the antero-posterior and dorsoventral axes in the retina and tectum confer the positional information and control the topographical projection of retinal axons. For a systematic screening of topographic molecules expressed in the chick retina, we performed restriction landmark cDNA scanning (RLCS). cDNA samples were prepared from mRNA derived from the four regions respectively, the anterior, posterior, dorsal and ventral regions of the embryonic day 8 (E8) retina, when retinal axons reach the tectum and search for the positional cues on it. Regional specialization in the retina is thought to occur earlier, however, some region-speci®c expression of the responsible genes may persist to E8. We thus expected to isolate molecules which are involved in determination and maintenance of the regional speci®city in the retina, in addition to the molecules which are directly involved in the topographical projection.
Identi®cation of aldehyde dehydrogenases by RLCS
RLCS is a new cDNA display system, in which a great number of cDNA species are two-dimensionally displayed as spots re¯ecting the expression levels of respective genes (Suzuki et al., 1996) . With this method, cDNAs are prepared with an anchor primer, digested with a ®rst restriction enzyme, and radiolabeled at the ends. Next, cDNA fragments carrying the primer sequence are collected and subjected to ®rst dimensional agarose gel electrophoresis. After electrophoresis, the cDNA fragments in the gel are digested with a second restriction enzyme in situ, and then subjected to second dimensional electrophoresis. The cDNA fragments thus separated in two dimensions are ®nally displayed as spots by autoradiography. A resultant autoradiogram usually displays more than 2000 spots (Fig. 1A,B) . Using multiple combinations of restriction enzymes, a comprehensive screening for molecules which are asymmetrically distributed in the retina is possible. We searched for spots that gave different signal intensities between anterior and posterior retina, or between dorsal and ventral retina. By this procedure, we detected about 200 spots that were detected preferentially on one side of the two axes, and successfully identi®ed a number of molecules with various asymmetrical expression patterns in the developing chick retina. cDNA fragments were recovered from the gel corresponding to each spot, and subcloned into plasmids for sequencing and to use as probes for further cDNA cloning.
Among the asymmetric molecules along the dorsoventral axis, we found two aldehyde dehydrogenases which may catalyze the oxidation of retinaldehyde to RA: one was a novel molecule and the other was RALDH-1 (also called AHD2 in mouse; Green®eld and Pietruszko, 1977; Lee et al., 1991; McCaffery et al., 1992) . The novel aldehyde dehydrogenase was ®rst identi®ed in a RLCS gel using BglII as the ®rst restriction enzyme. The signal for this molecule was speci®cally detected on the ventral side (Fig. 1C,D) . We tentatively named this molecule V/BglII #1 after the expressed region, the ®rst restriction enzyme used, and the spot number. Northern blot analysis veri®ed that the V/BglII #1 transcript of 4.9 kb was speci®cally expressed in the ventral retina (Fig. 1G) . The same molecule was identi®ed again in the gel using BclI as the ®rst restriction enzyme (not shown). On the other hand, RALDH-1 was identi®ed as a dorsal-speci®c molecule, D/SspBI #1 (Fig.  1E,F) . In addition to this spot, this molecule was repeatedly identi®ed as D/BamHI #1, D/BlnI #1, or D/NcoI #1 in different gels (not shown). RALDH-1 is an RA-generating enzyme, which is known to be expressed in the dorsal region of the vertebrate retina. Northern blot analysis showed that RALDH-1 transcript of 2.7 kb was speci®cally expressed on the dorsal side (Fig. 1H) .
To obtain the full-length clone of V/BglII #1, we screened a chicken cDNA library of E8 whole retina, and ®nally obtained multiple overlapping clones covering the entire coding region. Sequence analysis of these clones revealed that the coding region of V/BglII #1 is 1536 bp in length encoding 512 amino acid residues, with a calculated molecular mass of 54 kDa. A search for similar sequences in DNA databases revealed that V/BglII #1 is highly homologous to the aldehyde dehydrogenases. Human aldehyde dehydrogenase 6 (hALDH6) had the highest similarity with V/BglII #1. We next isolated a mouse homologue of V/BglII #1 from a neonatal mouse eye cDNA library. The mouse homologue also consists of 512 amino acid residues and showed high homology with the chick V/BglII #1 (85% identical) (Fig. 2) . hALDH6 also consists of 512 amino acid residues with a high degree of sequence similarity through the entire coding region with chick and mouse V/BglII #1 (86% and 94%, respectively) (Fig. 2) . Mouse V/BglII #1 expression was detected by RT-PCR in some adult tissues including kidney, stomach and salivary gland, which are known to express hAldh6 at high levels (not shown). These results suggested that V/BglII #1 is the homologue of hALDH6. Here, we designate V/BglII #1 as RALDH-3 because this molecule was revealed to have RA-generating activity (see below).
RALDH-3 showed relatively low similarity with RALDH-1: 70% between chick RALDH-3 and RALDH-1, and 65% between mouse RALDH-3 and RALDH-1. In particular, the amino-terminal residues of RALDH-3 were not conserved in RALDH-1 molecules (Fig. 2) , and the total number of amino acid residues of RALDH-1 is smaller than that of RALDH-3. However, the essential amino acid residues of the active site (Glu-280 and Cys-314) and the NADbinding domain for aldehyde dehydrogenases were conserved in RALDH-3 (Fig. 2) . These results suggested that RALDH-3 is enzymatically active.
RA synthesis by RALDH-3
The vertebrate retina is known to express mainly two RAgenerating aldehyde dehydrogenases: one shows a dorsalspeci®c and the other a ventral-speci®c distribution (McCaffery et al., 1992) . As mentioned above, RALDH-1 was identi®ed as a dorsal speci®c clone D/SspBI #1 in our screening. RALDH-3 (V/BglII #1) was, therefore, expected to be a ventral RA-generating enzyme which has not been cloned to date. In addition, hALDH6 has been reported to have RA-generating activity (Yoshida et al., 1998) . If RALDH-3 has the enzymatic activity to convert all-transretinal to RA, RA should be produced by RALDH-3-expressing cells from all-trans-retinal added to the culture medium. We used F9 reporter cells for detection of RA in the conditioned medium. This cell line was established from F9 teratocarcinoma cells by transfection with b-galactosidase gene under the control of the RA-responsive element of the RAR b gene . When exposed to the conditioned media of the cells expressing chick RALDH-3 and mouse RALDH-3, F9 reporter cells showed a high level of reporter gene activation (Fig. 3A,B) . In contrast, the conditioned media of cells transfected with the control plasmids did not induce expression of the b-galactosidase gene: control plasmids used are RCAS/alkaline phosphatase ( Fig.  3C ) and pZeoSV/mRALDH-3 (2) (not shown). These results indicated that RALDH-3 can catalyze the conversion of retinaldehyde to RA. As two retinaldehyde dehydrogenases, RALDH-1 and RALDH-2, have already been identi®ed (Green®eld and Pietruszko, 1977; Lee et al., 1991; Dockham et al., 1992; Godbout, 1992; Zhao et al., 1996; Ono et al., 1998; Sockanathan and Jessell, 1998) , we designate this novel RA-generating enzyme as RALDH-3, the third retinalaldehyde dehydrogenase. RALDH-3 is thus likely to be the ventral-speci®c RALDH which has not been cloned to date.
RALDH-3 and RALDH-1 expression during chick embryonic development
We performed in situ hybridization analysis on chick embryos to assess the spatial and temporal expressions of Raldh-3 mRNA during development, together with that of Raldh-1 mRNA because detailed analyses had not been done. We mainly analyzed their expressions in the eye region. Raldh-3 transcripts were not detected until stage 9, and detected ®rst at stage 9 1 faintly in the ventral region of the head (not shown). At this stage, the anterior neural folds are elevated and fusing. At stage 10, when the neural pore is about to close, the expression of Raldh-3 extended laterally and covered the prospective eye region (Fig. 4A,a) . At stage 12, the Raldh-3 signals were maintained in the ventral eye region (Fig. 4A,b) . Noteworthy is that this expression was observed in the surface ectoderm. After invagination of the optic vesicle (at stage 14), the expression of Raldh-3 became strong at the surface ectoderm covering the ventral region of the optic cup and the prospective nasal area (Fig. 4A,c) . In section hybridization at this stage, strong expression was observed in the ventral portion of the presumptive pigment epithelium and neural retina as well as in the surface ectoderm ( Fig. 4A,d ). At stage 16, the expression in the surface ectoderm weakened and was gradually localized to the ventral eye region (Fig. 4A,e) . In the whole-mount hybridization at stage 20 (E3), a high level of Raldh-3 expression was observed in the ventral retina, nasal pit, dorsal part of the otic vesicle, and posterior somites (Fig. 4A,f) . In section hybridization at this stage, we observed the expression of Raldh-3 in the ventral eye region including the neural retina and pigment epithelium, with weak expression at the ventral surface ectoderm (Fig. 4A,g ). At E6, the Raldh-3 signals were restricted to the ventral retina, and especially intense expression was observed in the whole layer in the peripheral ventral region (Fig. 4A,h ). The Raldh-3 signals were also observed in the eyelid primordium (arrowhead in Fig. 4A,h ). At E8, the expression remained in the ventral retina and the eyelid primordium surrounding the eye (Fig. 4A,i) . At this stage, strong signals in the retina were detected in the whole layer in the peripheral region, but in the inner nuclear layer in the centro-ventral region (Fig. 4A,i) .
The onset of Raldh-1 expression was later than that of Raldh-3 expression. At stage 10 to 12, Raldh-1 expression was not yet detected including the surface ectoderm (Fig.  4Ba,b) . After invagination of the optic vesicle, a faint expression of Raldh-1 was ®rst detected in the dorsal region of the neural retina at stage 14 (Fig. 4B,c,d ). The Raldh-1 expression thus coincided with the beginning of optic cup formation. At stage 16, the expression in the dorsal retina became strong and clear (Fig. 4B,e) . At stage 20 (E3), the Raldh-1 expression was con®ned to the dorsal retina, but was weaker than the Raldh-3 expression at the same stage (compare Fig. 4A ,f,g with Fig. 4B,f,g ). At E6 and E8, Raldh-1 expression was restricted to the dorsal half of the retina, but exceptionally, some signals were detected in the vicinity of the optic ®ssure (arrows in Fig. 4B,h,i) . The Raldh-1 expression in the retina was distributed throughout the layers (Fig. 4B,h,i) .
Furthermore, the developmental expression of the Raldh-3 and Raldh-1 transcripts in the chick retina was also examined by Northern blot analysis from E6 to E12, using total RNA prepared from the dorsal or ventral third of the retina. Raldh-3 transcript was detected speci®cally in the ventral side during the developmental stages examined (Fig. 5) . Peaking at E8, the expression gradually decreased thereafter, and only a faint signal was detected at E12 (Fig. 5) . On the other hand, the expression of Raldh-1 transcripts was detected prominently in the dorsal sides, but a faint signal was also observed on the ventral side of E6 retina (Fig. 5) . This is probably due to the expression around the optic ®ssure. Peaking at E6, the expression decreased steadily, but was still at a signi®cant level at E12.
Raldh-3 and Raldh-1 expression during mouse embryonic development
We also examined the expression patterns of mouse Raldh-3 and Raldh-1 during embryonic development. We performed whole-mount in situ hybridization on embryos from E8.5 to E11.5 and section in situ hybridization on embryos from E9.5 to E14.5. Expression of the mouse Raldh-3 was ®rst detected at E8.75, before the neural tube closure, in the surface ectoderm of the prospective eye ®eld (Fig. 6A,a) . At E9.0, the Raldh-3 expression expanded on the surface ectoderm broadly in the ventral facial region (Fig. 6A,b) . At E9.5, when the optic vesicle begins to invaginate, the Raldh-3 signals further spread and covered the entire eye ®eld (Fig. 6A,c) . In addition, we observed the expression along the posterior spinal cord. The Raldh-3 expression at this stage mainly resided in the surface ectoderm including the prospective lens placode, but also in the dorsal optic cup signi®cantly (Fig. 6A,d ). At E10.0, the expression in the facial region was attenuated and divided between the eye region and the nasal pit (Fig. 6A,e) . At this stage when the lens placode invaginates, the signals in the eye were mainly detected in the lens pit (Fig. 6A,f) , whereas the chick lens pit was negative for Raldh-3 expression (Fig.4A,c,d ). Interestingly at E11.5, the Raldh-3 signal almost disappeared from the surface ectoderm although it was positive at the upper edge of the mandibular arch (Fig.  6A,g ). In section hybridization, Raldh-3 expression was detected not only in the ventral third of the retina but also faintly in the dorsal part of the retina (Fig. 6A,h ). At this stage when the lens placode developed into the lens vesicle, Raldh-3 expression in the lens vesicle disappeared. At E14.5, weak signals were detected in the ventral retina (Fig. 6A,i) .
As observed in chick embryos, the onset of Raldh-1 expression in mouse embryos appeared to occur later than that of Raldh-3 expression and again coincided with the beginning of optic cup formation. No signal was detected at E8.75 (Fig. 6B,a) , and faint signals were ®rst detected in the dorsal optic vesicle at E9.0 (Fig. 6B,b) . Thereafter (E9.0±E10.0), the expression level gradually increased (Fig.6B,c±f) . At E11.5, a high level of Raldh-1 expression was observed in the dorsal retina but a low level expression began in the ventral retina (Fig. 6B,g,h) . At this stage, Raldh-1 expression is evident in the lens vesicle in place of Raldh-3. Interestingly, at E14.5, the Raldh-1 expression was detected equally in both the dorsal and ventral periphery of the retina, as well as in the lens epithelium (Fig. 6B,i) .
Raldh-3 expression in Pax6 mutant rats
The paired-like homeobox-containing transcription factor Fig. 3 . RA-producing activity of RALDH-3. F9 reporter cells were incubated with conditioned media and developed with X-gal: chick Raldh-3-transfected CEFs (A), mouse Raldh-3-transfected COS-7 cells (B), and mock-transfected CEFs (C). Activity of b-galactosidase was observed when exposed to the conditioned media of the cells expressing Raldh-3, indicating that Raldh-3 can generate RA from retinaldehyde.
Pax6 is known to have an important role in the development of the eye in many animal species including Drosophila. In humans, heterozygous Pax6 mutations give the ocular defects aniridia (Jordan et al., 1992 ) and Peter's anomaly (Hanson et al., 1994) . In mouse (Hill et al., 1991) and rat (Matsuo et al., 1993; Osumi et al., 1997) , heterozygous Fig. 4 . Expression patterns of Raldh-3 and Raldh-1 during chick development. The localization of Raldh-3 (A) and Raldh-1 (B) mRNA was detected by in situ hybridization using Dig-labeled antisense riboprobes. Embryos were staged according to Hamburger and Hamilton (1951) . mutant animals exhibit the phenotype known as`Small eye' (Sey). In the homozygotes, eyes and nasal cavities do not develop, and death occurs soon after birth (Hill et al., 1991; Matsuo et al., 1993; Osumi et al., 1997) . Although the precise role of Pax6 in the development of the eye and nose is not well understood, Pax6 is considered a key molecule for the development. Pax6 is known to regulate retinoid signaling in the eye region as well as in the nasal region. In Pax6 mutant mice, the local production of RA in the eye region and nasal region is disrupted (Anchan et al., 1997; Enwright and Grainger, 2000) . If RALDH-3 or RALDH-1 is important for the development of the eye region, it is expected that Raldh-3 or Raldh-1 gene expression would be altered in Pax6 mutant animals. We therefore examined the Raldh-3 and Raldh-1 expressions in Pax6 mutant rats (rSey 2 ). Fig. 5 . Northern blot analysis of Raldh-3 and Raldh-1 mRNAs in chick retina during development. Total RNA (10 mg) from the dorsal or ventral retina at E6, E8, E10 and E12 was analyzed with the probe for Raldh-3 or Raldh-1. The same membrane was re-hybridized with the GAPDH probe to verify the amount of RNA loaded in each lane. In E11.5 wild-type rat embryos (corresponding to E9.5 mice), the Raldh-3 expression was detected broadly at the facial surface ectoderm covering the prospective eye region and nasal region as observed in mouse embryos (Fig. 7A) . In mutant rat (rSey 2 /rSey 2 ) embryos at this stage, the facial surface ectoderm appeared normal although the lens and nasal placodes had not developed. However, the Raldh-3 expression was completely absent from the surface ectoderm (Fig. 7B) . At E13.5, mutant rat embryos lack the lens, nasal pit, and retina. At this stage, no Raldh-3 expression was detected in the mutant, while strong Raldh-3 expression was observed in the retina and nasal pit in the wild type (not shown).
Since the onset of Raldh-1 expression was later than that of Raldh-3 expression, we could not detect Raldh-1 either in wild-type embryos or mutant embryos at E11.5 (not shown). At E13.5, while strong Raldh-1 expression was observed in the dorsal retina in the wild type (Fig. 7C) , no Raldh-1 expression was detected in the mutant (Fig. 7D ). However, it is possible that this resulted from the lack of tissues of lens and retina in the mutant rats.
Discussion
Little is known about the gene cascades underlying the formation of regional speci®cation that leads to the establishment of topographical maps in the central nervous system. This comes from the simple fact that only a small number of molecules that are implicated in these gene cascades have been identi®ed to date. Compared with PCR-based methods, RLCS is more quantitative since the intensity of each spot on the two-dimensional gel directly re¯ects the expression level of a corresponding gene. Thus, this method enabled us to screen comprehensively for the topographic molecules. We have successfully identi®ed a number of molecules with asymmetrical expression patterns along the antero-posterior or dorso-ventral axis in the chick retina which may contribute to the regional speci®cation. These, including Eph receptors and ephrins (Cheng et al., 1995; Marcus et al., 1996; Braisted et al., 1997) , were revealed to be enzymes, secretory factors, transcription factors, transmembrane proteins, and so on (to be published elsewhere). In this paper, we report on the identi®cation and expressional analysis of RALDH-3, a novel retinaldehyde dehydrogenase in the ventral retina, together with RALDH-1 in the dorsal retina.
In the early developmental stage, the RA gradient (ventral high) along the dorso-ventral axis is considered to be important for the regional speci®cation, especially for the ventral retinal formation. Hyatt et al. (1996) reported that RAsoaked beads implanted in the dorsal optic primordium of zebra®sh induced double ventral-like retina, and RA-deprivation caused elimination of the ventral half of retina (Marsh-Armstrong et al., 1994) . In rat embryos, vitamin A de®ciency caused abnormalities in the ventral eye formation (Warkany and Schraffenberger, 1946) . Retinoid signaling is transduced by two families of nuclear receptors, the three RAR (a, b and g) and three RXR (a, b and g) isoforms (Chambon, 1996) . Similar symptoms were observed in the compound knock-out mice for RA receptors, in which the ventral half of the retina was reduced in size (Kastner et al., 1994; Ghyselinck et al., 1997) . Since RA receptors are evenly expressed in the developing retina, it is assumed that this restriction results from the asymmetric distribution of the ligand. Thus, a proper RA level and distribution is a prerequisite for the formation of the eye anlage and invagination of the optic vesicle, and a ventral-speci®c retinaldehyde dehydrogenase is responsible for the RA-gradient formation (McCaffery et al., 1992) . We showed that RALDH-3 catalyzes the oxidation of retinaldehyde to RA. RALDH-3 showed the highest sequence similarity to human aldehyde dehydrogenase 6 (hALDH6). This was a surprise because hALDH6 is an enzyme expressed at low levels in many tissues, but at higher levels in stomach, kidney and salivary gland (Hsu et al., 1994) , and its expression in the retina has not been described. However, mouse Raldh-3 also showed a high level of expression in some adult tissues like kidney, stomach and salivary gland (our unpublished data), supporting the view that RALDH-3 is the orthologue of hALDH6.
In the early developmental stages of chick (stage 9 1 ±12) and mouse (E8.75±E9.0) embryos, Raldh-3 expression was observed in the ventral portion of the prospective eye regions. On the other hand, another RA-generating enzyme, Raldh-1, which is expressed in the dorsal portion of the Fig. 7 . Expression of Raldh-3 and Raldh-1 in Pax6 mutant rat (rSey 2 /rSey 2 ) embryos. Raldh-3 expression was observed in the facial surface ectoderm covering the eye and nasal region of the E11.5 wild-type embryo (A). In contrast, the Raldh-3 expression was absent in the rSey 2 /rSey 2 embryo (B). Raldh-1 expression was detected in the dorsal retina of the E13.5 wild-type embryo (C). In E13.5 rSey 2 /rSey 2 embryo, the Raldh-1 expression was not observed (D). In the mutant, clear structures of the retina and nasal pit were absent. The outline of the prospective eye region is circled by a dotted line. retina, was not detected at that time. Thus, these expression patterns imply that ventral-high and dorsal-low RA gradients may be generated at these stages in the prospective eye regions. The time of dorso-ventral axis formation appears to be after stage 11 and before stage 13/14 in chick, thus brie¯y preceding or coinciding with the invagination of the optic vesicles (Crossland et al., 1974; Matsuno et al., 1992) . Here, it should be noted that in these early developmental stages, the expression of Raldh-3 was mainly detected at the surface ectoderm both in chick and mouse. These observations suggest that RA generated at the surface ectoderm diffuses into the neural ectoderm, and functions in the formation of the dorso-ventral axis in the retina. However, the possibility is not excluded that RA exerts its functions via a secondary secretory factor which is produced at the surface ectoderm and diffuses into the neural ectoderm. When the expression of Raldh-1 begins in the dorsal optic cup, a cytochrome P450 oxidase CYP26, which breaks down RA, is expressed in the same region (McCaffery et al., 1999) . It is likely that overlapped expressions help the formation of the ventralhigh dorsal-low RA gradient. COUP-TFII predominantly expressed in the dorsal part of the retina has been shown to repress the transcriptional activity of RA receptors by heterodimerization (Jonk et al., 1994; McCaffery et al., 1999) . Thus, multiple mechanisms seem to be involved in the asymmetrical RA signaling along the dorso-ventral axis in the retina.
At the later developmental stages (E6±E8 in chick, E10.0±E14.5 in mouse), we observed that the expression patterns of Raldh-3 in mouse differed from those in chick. In mouse, Raldh-3 was expressed not only in the ventral retina, but also in the dorsal retina albeit it is weak. In contrast, chick Raldh-3 expression was ventral-retina speci®c. A similar expression pattern was observed for Raldh-1. In mouse, Raldh-1 expression was observed predominantly in the dorsal retina but signi®cantly also in the ventral retina, while the expression of chick Raldh-1 was restricted to the dorsal retina throughout the development (compare Figs. 4A,h,i with 6A,h,i, and Figs. 4B,h,i with 6B,h,i; McCaffery et al., 1991) . In addition, only in mouse, Raldh-3 and Raldh-1 were expressed in the lens pit and lens vesicle, respectively. We do not know at present the meaning of the differences in the spatial regulation of these genes between the two species. At the later developmental stages, however, RA is observed at a high level both in the dorsal and ventral parts of the retina, and there seems to be no signi®cant difference in the RA concentration between the two parts (Mey et al., 1997) . It is possible that RA synthesized by two RALDHs has a common function in the dorsal and ventral retina at the later stages. RA plays numerous roles during embryogenesis, in cell growth and cell differentiation for example (Love and Gudas, 1994) . Thus, RA in the retina may also regulate cell growth and differentiation. In addition, it was reported that RA stimulates neurite outgrowth in some neurons (Plum and Clagett-Dame, 1996; Corcoran and Maden, 1999) , and that coloboma of the optic nerve was observed in RA receptor knock-out mice (Lohnes et al., 1994) . These results suggest that RA is necessary for axonal growth of retinal ganglion cells at the later developmental stages. This notion is consistent with the observation that the RA concentration is maintained at a high level until the retinal axonal growth is completed (McCaffery et al., 1993) .
In addition to the expression in the eye region, Raldh-3 was also expressed in the region of the nasal pit, a part of the otic vesicle and the posterior somites in chick, and along the posterior spinal cord in mouse. The expression in the region of the nasal pit is particularly intriguing. At E9.5 in mouse, the Raldh-3 expression was observed in the surface ectoderm including the lens placode and nasal placode (Fig.  6A,c) . At E11.5, high levels of expression were con®ned to the nasal pit as well as to the ventral retina (Fig 6A,g ). Similar expression patterns were observed in chick embryos (Fig. 4A,f) . It has been reported that retinoid signaling is essential for the normal development of the olfactory pathway (LaMantia et al., 1993; Anchan et al., 1997; Whitesides et al., 1998) . RA produced in the nasal region is believed to contribute to neuronal differentiation and axon growth in the olfactory pathway (LaMantia et al., 1993; Anchan et al., 1997) . The time and the area of RA production in this region, which was assessed in the mice carrying an RAresponsive transgene (LaMantia et al., 1993) , appears to coincide with the expression patterns of Raldh-3. Since expressions of Raldh-1 and Raldh-2 are at low levels or absent in this region (Niederreither et al., 1997; Haselbeck et al., 1999) , RALDH-3 is likely to be the main enzyme to produce RA in the nasal region.
It is noteworthy that eyes and nasal cavities do not develop in Pax6 homozygous mutants (Pax6 2/2 ) of mouse and rat (Hill et al., 1991; Matsuo et al., 1993; Osumi et al., 1997) . In Pax6 mutant mice, RA production in the eye and nasal regions is greatly decreased (Anchan et al., 1997; Enwright and Grainger, 2000) . We found that the expression of Raldh-3 overlapped with that of Pax6 at the surface ectoderm around the prospective eye and nasal region (Li et al., 1994; Grindley et al., 1995) . As expected, in the rSey 2 /rSey 2 rats in which the Pax6 gene is mutated, Raldh-3 expression in the surface ectoderm was completely absent (Fig. 7) . This ®nding suggests that Raldh-3 is a downstream target of Pax6, and Pax6 exerts its functions at least in part through RA produced by RALDH-3. In Pax6 2/2 animals, the interaction between the optic vesicle and the surface ectoderm does not occur, and as a result, the lens placode is not formed and the optic vesicle fails to develop into the optic cup (Grindley et al., 1995) . Pax6 is considered to render the surface ectoderm responsive to a lens induction signal from the optic vesicle through RA (Li et al., 1994) . This hypothesis is consistent with the ®nding that primary aphakia (failure of lens formation) is observed in knockout mice of RA receptors (Lohnes et al., 1994) . In addition, Pax6 2/2 rats show impaired migration of neural crest cells from the anterior midbrain into the eye and nasal regions: the facial crest cells reach the area around the optic vesicle, but do not migrate any further (Matsuo et al., 1993; Anchan et al., 1997) . These crest cells do not express Pax6 (Matsuo et al., 1993) , but are known to express RA receptors (OsumiYamashita et al., 1990) . Thus, it is likely that the neural crest cells respond to RA produced by RALDH-3 to migrate to their destinations.
In summary, our analysis on RALDH-3 during chick and mouse development suggests that this molecule is responsible for the RA production in the ventral eye region, which is considered to be a prerequisite for the establishment of dorso-ventral asymmetry in the retina. Expression of Raldh-3 begins in the surface ectoderm overlying the ventral portion of the prospective eye region and then shifts to the neural ectoderm of the optic vesicle during development. We assume that this phenomenon is related to the mutual dependency of lens and optic vesicle development, though how is not clear. And RALDH-3 may also play important roles in other tissues including the olfactory system. Further studies on the relationship between Pax6 and RALDH-3 would be required to gain insights into the developmental mechanisms of the eye and nose. Genetic manipulation experiments of Raldh-3 are now possible, and will shed light on the biological functions of RA.
Experimental procedures

Animals
Fertilized white leghorn chicken eggs were incubated at 37.58C under humidi®ed condition, and embryos were staged by Hamburger and Hamiltons' criteria (Hamburger and Hamilton, 1951) . Mouse embryos were obtained from pregnant C57BL/6J mice. The stage of embryos was determined by designating noon on the day of the vaginal plug as embryonic day 0.5 (E0.5). The day of birth was considered postnatal day 0 (P0). Embryos of the Pax6 mutant rat (rat Small eye, rSey 2 , originated from the Sprague±Dawley rat colony) were obtained from intercrosses of heterozygous rSey 2 rats (Osumi et al., 1997) .
Restriction landmark cDNA scanning (RLCS) and cDNA spot cloning
RLCS was carried out to identify molecules which show region-speci®c expression in the developing chick retina. Poly(A)
1 RNA from the dorsal or ventral third of E8 chick retina was prepared and analyzed as previously described by Suzuki et al. (1996) . We used twenty different six-cutters as the ®rst restriction enzyme, and the second restriction enzyme was ®xed to HinfI. Twenty sets of autoradiograms with the different ®rst restriction enzymes for the ventral and dorsal regions were obtained. For the analysis, images of autoradiograms were digitized using Fuji®lm Pictrostat Digital 400, and a comparison of signal intensities of each spot between the dorsal and ventral retina was performed with image analysis software, Melanie II 2-D PAGE (BioRad), on a Macintosh computer.
Some spots with signi®cantly higher signal levels in dorsal retina than in ventral retina, and vice versa, were subcloned as follows. A small piece of the gel containing the spot DNA was punched out and rehydrated, and the DNA was electroeluted. The eluted DNA fragments were then cloned into pBluescript KS (2) vector (Stratagene) using the PCR-mediated method. Brie¯y, the electroeluted spot DNA was ligated with an adaptor corresponding to the restriction site of the ®rst restriction enzyme, and a HinfI adaptor which has a NotI site. The spot DNA was ampli®ed with PCR (958C for 30 s; 958C for 30 s, 608C for 30 s and 748C for 1 min for 30±35 cycles; 748C for 5 min) using a M13 forward HT primer whose sequence resides in both adaptors. The PCR products were digested with a combination of the ®rst restriction enzyme and NotI, and subcloned by ligation in pBluescript KS (2) vector.
cDNA cloning of RALDH-3
Chick E8 whole retina cDNA libraries were constructed in lZAPII (Stratagene) using oligo (dT) primer and random primer. The cloned spot DNA (637 bp: BglII-NotI fragment) was labeled with [a-32 P] dCTP by a random priming method (Megaprime DNA Labeling system, Amersham Pharmacia Biotech) and used as a probe for screening. Thirteen positive clones were isolated and identi®ed by restriction mapping and nucleotide sequencing. All of the clones were revealed not to encode the ®rst methionine codon: the longest clone CO-18 was missing the ®rst 30 amino acids. Therefore, the random primed cDNA library was screened with the AccISacI fragment (nucleotide residues 127±843) to obtain the entire coding region. Eight positive clones were isolated including clone CR-5 which encoded the entire coding region. Clones CO-18 and CR-5 were sequenced on both strands.
For isolation of mouse RALDH-3 cDNA clones, a P0 eye cDNA library was constructed with poly(A) 1 RNA and random primer in lZAPII. A probe for screening of mouse RALDH-3 cDNA was ampli®ed from P0 eye total RNA by RT-PCR using degenerate primers based on the conserved amino acid sequences between human ALDH6 and chick RALDH-3 as follows: sense primer, 5 H -GATATTTATMAACAATGAATGGCACG-3 H , and antisense primer, 5 H -GACATTTTAAAGCCACCAAAKGG-3 H , which correspond to amino acid residues 34±40 and 476±483, respectively. The mouse lZAPII cDNA library was screened with the [a-32 P] labeled cDNA fragment. Five positive clones thus isolated were sequenced partially, and the longest clone MR-6 carrying the entire coding region was sequenced completely. The DNA sequencing was performed by the diedeoxy chain-termination method with a DNA sequencer (Model 377, PE Biosystems) using a combination of vector primers and insert-speci®c primers. The initial database search was performed using the Blast Network Service of the National Center for Biotechnology Information. The numbering of the nucleotide residues begins from the ®rst ATG codon. The sequences for chick RALDH-3 and mouse RALDH-3 thus obtained have been deposited in GenBank (accession number: AF246710 for chick and AF246711 for mouse).
Northern blot analysis
Total RNA was prepared using Ultraspec RNA reagent following the manufacture's protocol (Biotecx Laboratories), and poly(A)
1 RNA was puri®ed with oligo (dT)-Dynabeads (Dynal). Ten micrograms of total RNA or 2 mg of poly (A) 1 RNA per sample was separated on formaldehyde-agarose gel, and transferred to Hybond-N nylon membranes (Amersham Pharmacia Biotech). The cloned spot DNA for RALDH-1 (nucleotide residues 1041±1565; GenBank accession number X58869) and RALDH-3 (nucleotide residues 3233±3864), and chick glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA for the control (nucleotide residues 218±794; GenBank accession number K01458) were radiolabeled by the random priming method and used as probes. Prehybridization and hybridization were performed with the same solution (5£ SSC, 50% formamide, 5£ Denhardt's solution, 0.5% SDS and 200 mg/ ml sonicated salmon sperm DNA) at 428C. Finally, the membrane was washed several times in 0.2£ SSC with 0.1% SDS at 608C, and exposed to X-ray ®lms (Konica, Japan) for autoradiography. Molecular sizes of transcripts were estimated by comparison with the 0.24±9.5 Kb RNA ladder (Gibco BRL).
Analysis of RA-generating activity of RALDH-3
The enzyme activity of RALDH-3 to convert all-transretinal to RA was assessed with a retinoid-responsive reporter cell line derived from F9 teratocarcinoma , which expresses LacZ gene in response to RA. For this assay, chick Raldh-3 was expressed in the chick embryonic ®broblasts (CEFs) using a replication-competent avian retrovirus vector, RCAS-NS, and mouse Raldh-3 was expressed in COS7 cells using a mammalian expression vector, pZeoSV2 (Invitrogen). To prepare chick expression vector RCAS/cRALDH-3, a shuttle vector SLAX-NS and RCAS-NS were newly constructed. SLAX-NS was constructed by inserting a NotI-SpeI fragment carrying the 5 H -untranslated region of the src gene which confers ef®-cient expression on heterologous coding sequences (Morgan and Fekete, 1996) and a polylinker sequence into pBluescript KS (2). RCAS-NS is a modi®ed vector of RCAS-BP (B) (Morgan and Fekete, 1996) , in which NotI and SpeI sites have been added at the ClaI site. For the construction of RCAS/cRALDH-3, the entire coding region (nucleotide residues 1±1536) was once inserted into the NcoI and HindIII sites of SLAX-NS. Then, the NotI-SpeI fragment of SLAX/cRALDH-3 was transferred into the NotI and SpeI site of RCAS-NS. For the control, RCAS/alkaline phosphatase was prepared. To yield mouse expression vectors, NotI-NotI fragment (nucleotide residues 213 to 2359) of mouse RALDH-3 was inserted into the NotI site of pZeoSV2 in the right orientation or reverse orientation to yield pZeoSV/mRALDH-3 (1/2), respectively. Transfections were carried out with LipofectAMINE (Life Technologies) according to the manufacturer's protocol. CEFs were prepared from E6 embryos as described previously (Morgan and Fekete, 1996) except that the culture medium was DMEM/Ham F12 (1:1), supplemented with antibiotics and 10% fetal bovine serum (FBS). COS7 cells were grown in DMEM supplemented with antibiotics and 10% fetal FBS. After 24-h incubation following the transfection, the transfected cells were replaced onto 100-mm plates and maintained in a 5% CO 2 incubator at 378C. The next day, alltrans-retinal (Sigma) was added to each cell at a ®nal concentration of 80 mM under dim light. The conditioned medium was collected after 24 h.
F9 reporter cells were grown on 0.1% gelatin-coated 35-mm plates to 80% con¯uence in L15-CO 2 (Specialty Media) containing 20% FBS and 0.8 mg/ml G418; L15-CO 2 medium was modi®ed with 112/FVM. The growth medium was then aspirated and replaced with 1 ml of a mixture of conditioned medium (0.5 ml) and serum free L15-CO 2 medium (0.5 ml) containing 10 mg/ml Insulin-TransferrinSelenite (Boehringer Mannheim) and 8.0 mg/ml glucose. After 3 h, 1 ml of serum free L15-CO 2 medium was added and the cells were incubated for another 18 h. The cells were ®xed with 1% gulutaraldehyde in 0.1 M sodium phosphate buffer (pH 7.0) and 1 mM MgCl 2 . Finally, LacZ expression was visualized by incubation with 5-bromo-4-chloro-3-indorlyl-b-garactopyranoside (X-gal) solution (40 mg/ml X-gal, 1 mM MgCl 2 , 10 mM sodium phosphate buffer, 150 mM NaCl, 3.3 mM potassium ferricyanate, and 3.3 mM potassium ferrocyanate) for 5±12 h at 378C.
In situ hybridization
Whole-mount in situ hybridization with digoxigeninelabeled RNA probes was performed as described previously (Wilkinson, 1992) . Templates used for probe preparation were as follows: the 632-bp fragment of chick Raldh-3 (nucleotide residues, 3233±3864), the 525-bp fragment of chick Raldh-1 (1041±1565), the 444-bp fragment of mouse Raldh-3 (1916±2359) , and the 432-bp fragment of mouse RALDH-1 (1462±1893). The template for mouse Raldh-1 was prepared by RT-PCR. The probe used for rat embryos was the 727-bp fragment (213 to 714) of mouse Raldh-3.
Section in situ hybridization was carried out as follows. Dissected embryos were ®xed in 4% PFA in PBS overnight at 48C, and in®ltrated with a graded sucrose series. Embryos were then embedded in OCT compound (Miles) and sectioned at 14 mm. Samples were post®xed in the 4% PFA for 15 min and washed in PBS for 5 min. Next, samples were treated with 10 mg/ml proteinase K for 6±8 min at room temperature, re®xed in the 4% PFA, and acetylated in 0.1 M triethanolamine. After a wash with PBS, samples were prehybridized for 1 h at 558C, and hybridized for 16 h. Digoxigenine-labeled RNA probes were denaturated for 5 min at 858C before use. The hybridization solution was as follows: 0.1 mM EDTA, 10 mM Tris±HCl, pH 7.4, 0.6 M NaCl, 0.1% SDS, 400 mg/ml yeast tRNA, 1£ Denhardt's solution, and 10% dextran sulfate. After hybridization, samples were washed in 4£ SSC at 508C, then digested with 10 mg/ml RNase A for 1 h at 378C, and washed in 2£ SSC and 0.1£ SSC at 508C. Samples were ®nally incubated with alkaline phosphatase-conjugated anti-digoxigenine antibodies at room temperature in a humidi®ed chamber and developed with 4-nitroblue tetrazolium chloride (NBT) and 5-bromo-4-chloro-3-indolyl-phosphate (BCIP) overnight.
Images of whole-mounts were acquired using an Olympus SZH10 stereomicroscope equipped with a CCD camera (Minolta, Japan). Images of sections were acquired using the Zeiss Axioplan 2 microscope system. Figures were processed using Adobe Photoshop software on a Macintosh computer and were printed using a Fuji®lm Pictrostat Digital 400.
